个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Wang, J.[1] * ; Yi, T.[2] ; Dong, Y.[3] ; Ran, R.[4] ; Cao, F.[5] ; Li, Y.[6] ; Luo, Z.[7] ; Xu, Y.[8] ; Fu, Y.[9] ; Kuang, L.[10] ; Chen, G.[11] ; Qu, G.[6] ; Yin, Y.[12] ; Li, J.[6] ; Xu, X.[13] ; Chen, Y.[1] ; Song, Q.[14] ; Chu, Q.[1] ;
单位： [1]Tongji Hosp, Dept Thorac Oncol, Tongji Med Coll, Wuhan, Peoples R China [2]Xiangyang Cent Hosp, Xiangyang, Peoples R China [3]Xiangyang 1 Peopleshosp, Xiangyang, Peoples R China [4]Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Enshi, Peoples R China [5]Shiyan Renmin Hosp, Shiyan, Peoples R China [6]Cent Hosp Xiao Gan, Xiaogan, Peoples R China [7]Hubei Univ Med, Affiliated Taihe Hosp, Shiyan, Peoples R China [8]Jingzhou Cent Hosp, Jinzhou, Peoples R China [9]Xiangyang Hosp Tradit Chinese Med, Xiangyang, Peoples R China [10]Dongfeng Gen Hosp, Shiyan, Peoples R China [11]Jing Men 2 PeopleS Hosp, Jingmen, Peoples R China [12]Yichang Second PeopleS Hosp, Yichang, Peoples R China [13]Yichang Cent Hosp, Yichang, Peoples R China [14]Wuhan Univ, Renmin Hosp, Hubei Gen Hosp, Wuhan, Peoples R China
出处：
ISSN：

关键词： NSCLC Targeted therapy Real world study

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2019]版：
Q1 RESPIRATORY SYSTEM Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者：
第一作者单位： [1]Tongji Hosp, Dept Thorac Oncol, Tongji Med Coll, Wuhan, Peoples R China
推荐引用方式(GB/T 7714)：
Wang J.,Yi T.,Dong Y.,et al.A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer[J].JOURNAL OF THORACIC ONCOLOGY.2021,16(10):S1071-S1071.
APA：
Wang, J.,Yi, T.,Dong, Y.,Ran, R.,Cao, F....&Chu, Q..(2021).A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer.JOURNAL OF THORACIC ONCOLOGY,16,(10)
MLA：
Wang, J.,et al."A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer".JOURNAL OF THORACIC ONCOLOGY 16..10(2021):S1071-S1071

相关文献

[1]Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study [2]A Real-world Study: Efficacy and Safety of Anlotinib for Advanced Non-small Cell Lung Cancer(NSCLC) [3]Real-world Study Optimizing Nucleotide-analogues [4]Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study [5]ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC) [6]Real-world treatment patterns and clinical outcomes in EGFR-mutant unresectable locally advanced NSCLC (LA-NSCLC): A retrospective multicenter study of 367 patients. [7]Real-world treatment patterns and clinical outcomes in EGFR-mutant unresectable locally advanced NSCLC (LA-NSCLC): A retrospective multicenter study of 367 patients [8]Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705) [9]TAF Real World Study for Universal Effectiveness (TRUE) [10]Treatment (tx) patterns in resectable stage IAeIIIA non-small cell lung cancer (NSCLC) in China: Subgroup analysis of a global real-world (rw) study

资源点击量：426 今日访问量：0 总访问量：408 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）